GW pharma stops trading stock
In London The UK biotech company has decided to cease business at the London stock exchange and instead focus exclusively on New York's Nasdaq, they will however be keeping their HQ based in Cambridge.
Chief executive Juston Gover said - “We remain firmly committed to bringing important products to the global market, products that are both researched and manufactured in the UK". read the story in full here - http://www.independent.co.uk/news/business/news/cannabis-drug-gw-pharma-cancels-london-stock-market-listing-epilepsy-treatment-a7369756.html
S
Soft Secrets
